Corpus Christi Women’s Clinic Joins Research Ready Network, Offers Clinical Research as Care Option to Patients
Corpus Christi, Texas –
Physicians at Corpus Christi Women’s Clinic who will be participating as lead investigators in the clinical trials include: Charles Kirkham, M.D. (FACOG); Christine L. Canterbury, M.D. (FACOG); Leighanne Glazener, M.D. (FACOG); Jaime Pena, M.D. (FACOG); Benjamin Supnet, M.D. (FACOG); Danielle Inman, M.D. (FACOG); Heather Dixon, D.O.; Thomas Wilder, M.D. (FACOG); and Lindsey Vasquez, M.D. (FACOG).
As members of Elligo’s Research Ready network, Corpus Christi Women’s Clinic now has the infrastructure - people, processes, and technology - necessary to conduct research in its office, effectively keeping patients closer to home and under the care of their trusted physician. The practice’s extension into clinical research will help its patients benefit from treatments they might not otherwise be able to access.
In a statement from Corpus Christi Women’s Clinic, the physicians explained, “We often run into scenarios where we have exhausted all traditional treatment options with our patients. Complete patient care is important to us and this partnership will help ensure we can continue to provide options for even our toughest clinical cases.”
“Our ultimate goal is twofold: to make research accessible and the process simple,” said John Potthoff, Ph.D., CEO of Elligo Health Research. “That’s why we offer our services at no cost to our physician sites. For us, the best part is that with every new site, our ability to contribute to the future of medicine grows.”
About Corpus Christi Women’s Clinic
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
- Generative AI Transforms Clinical Study Report Development
September 16th 2025